Susan Akin, a 41-year-old patient at Caron Treatment Centers in Florida, began receiving Zepbound, another GLP-1 medication, for cocaine and alcohol addiction earlier this year
Individuals with type 2 diabetes were excluded from this particular trial, meaning the results reflect outcomes in adults with obesity or overweight but without diabetes
Last Updated July 2026 Author: Allison Jones, F-NP Medically reviewed by Dr
If you stop glutathione intravenous therapy, your skin may gradually return to its natural tone depending on lifestyle and sun exposure
The specific site you choose doesnt change how well the medication workswhat matters is proper technique and consistent rotation
Tirzepatide (Mounjaro, Zepbound) , a dual GIP/GLP-1 receptor agonist, has shown even greater results